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Catheter access to the left atrium is required for a number of
cardiac diagnostic and/or therapeutic procedures, includingFigure 1 Two iatrogenic atrial septal defects (IASDs) imaged in a reanimated hu
D: A 7F mapping catheter going through the most anteriorly positioned IASD. Can
inferior (RI) pulmonary veins enter into the atrium; in both sets of images, the top
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pulmonary vein isolation for treatment of paroxysmal andman heart from both A: the right atrium (RA) and B: the left atrium (LA). C,
nulas can be seen in frames B and D where the right superior (RS) and right
of the image is the superior aspect of the anatomy.persistent atrial ﬁbrillation (AF), left atrial appendage
occlusion, and some mitral valve repairs or replacements.
Typically these procedures require a transseptal puncture to
enter the left atrium by crossing the interatrial septum from
the right atrium. Doing so inevitably creates holes and/or
tears between the 2 chambers, which may be termed
iatrogenic atrial septal defects (IASDs). Such defects can
allow shunting of blood between the 2 atria. Fortunately, in
most patients these IASDs tend to close within a short time
without clinical consequences.1 Nevertheless, postprocedur-
ally IASDs have been seen in upwards of 87% of patientspen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.08.011
KEY TEACHING POINTS
 Whether or not they are fully imaged post
procedure, iatrogenic atrial septal defects (IASDs)
will be present following transseptal puncture
procedures. The ramiﬁcations of this defect must
be weighed against the potential beneﬁts of the
procedure.
 This paper clearly illustrates how an IASD can
present within a functioning human heart. These
clear passages within the septum should be
recognized and understood by those performing
the procedure.
 In the future, direct visualization methods may
provide greater insight into the frequency and size
of IASDs after transseptal procedures.
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up to 18 months or longer in 15% of patients.2Case report
Our laboratory was fortunate to receive, for research
purposes, a human heart deemed not viable for transplanta-
tion. The donor was a 72-year-old woman who terminally
suffered an intracranial hemorrhage. Previously, this patient
was diagnosed with intermittent AF and had undergone an
AF ablation procedure 2 months prior to organ donation. We
received the heart 6 hours post cross-clamp; it was then
prepared for reanimation as previously reported using
Visible Heart methodologies.3 With the heart functioning
in a 4-chamber working mode, we were able to directly
visualize 2 distinct IASDs in the atrial septal wall, and bothFigure 2 Cardiac ablation lines seen from the posterior aspect of the left
atrium. The 2 tissue clamps are seen going through the superior and inferior
pulmonary veins. Arrows indicate regions of ablation along the posterior
wall and neighboring PVs. LSPV ¼ left superior pulmonary vein; LIPV ¼
left inferior pulmonary vein; RSPV ¼ right superior pulmonary vein; RIPV
¼ right inferior pulmonary vein.were large enough to permit passage of a 7F catheter. We
presume that both IASDs were residuals of the ablation
procedure 2 months prior (Figure 1, and Supplemental
Video, available online). In this specimen, apparent healing
of the IASD had already begun to take place inasmuch as an
8.5F sheath (outer diameter of around 9.5F) was used for the
transseptal puncture and, at the time of the reanimation study,
the hole had healed to the point where a 7F catheter ﬁt almost
perfectly. This would suggest a contraction/healing of approx-
imately 1 mm in diameter from the time of the procedure.
Along with the IASDs, scar tissue formation as a result of
left atrial radiofrequency ablations was also observed as a
result of the pulmonary vein isolation procedures, with scar
lines seen on the posterior wall of the left atrium (Figure 2).
Discussion
Although most procedures requiring transseptal punctures
may have the inherent risk of creating IASDs, those risks
must be balanced against the potential beneﬁts of the
proposed procedure. Further, if an IASD remains, it is
important to consider whether or not the defect warrants
subsequent placement of a closure device.
In our case, owing to the limited medical history provided
with the heart, we are unable to ascertain the postprocedural
anticoagulation regimen, the status of the patient postoper-
atively, or the rationale for the atrial ablation of a 72-year-old
patient. Whether or not the IASD was a factor in the
documented intracranial hemorrhage of the patient cannot
be determined. However, the direct visualization of such
defects provides a new perspective on IASDs that may result
following a transseptal procedure. To our knowledge, only
atrial septal defects have been visualized via this method
previously.4 Potentially in the future, direct visualization
methods may provide greater insight into the frequency and
size of IASDs after transseptal procedures.
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